# FDA Inspection 1107120 - Acerta Pharma, LLC - September 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/acerta-pharma-llc/b43c9445-8732-48d3-9160-45fa6faa82a0
Source feed: FDA_Inspections

> FDA Inspection 1107120 for Acerta Pharma, LLC on September 27, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107120
- Company Name: Acerta Pharma, LLC
- Inspection Date: 2019-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1022880 - 2017-08-15](https://www.keypedia.com/records/fda_inspections/acerta-pharma-llc/5675dee6-83a0-4406-8041-78bdb956d41f)

Company: https://www.keypedia.com/companies/acerta-pharma-llc/445e0dfc-4e33-4fba-9a3f-09f03e513572

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c